Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recent developments in the chemotherapy of leishmaniasis.

Literature DB >> 3078072

Recent developments in the chemotherapy of leishmaniasis.

S L Croft.

Abstract

Entities: Disease

Mesh：

Year: 1988 PMID： 3078072 DOI： 10.1016/0165-6147(88)90258-1

Source DB: PubMed Journal: Trends Pharmacol Sci ISSN： 0165-6147 Impact factor: 14.819

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium.

Authors: Tatiana Shioji Tiuman; Tânia Ueda-Nakamura; Diógenes Aparício Garcia Cortez; Benedito Prado Dias Filho; José Andrés Morgado-Díaz; Wanderley de Souza; Celso Vataru Nakamura
Journal: Antimicrob Agents Chemother Date: 2005-01 Impact factor: 5.191

2. UDP-Gal: N-acetylglucosamine beta 1-4 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis.

Authors: Siddhartha Kumar Bhaumik; Manoj Kumar Singh; Subir Karmakar; Tripti De
Journal: Glycoconj J Date: 2008-11-13 Impact factor: 2.916

3. Enhanced action of amphotericin B on Leishmania mexicana resulting from heat transformation.

Authors: H Ramos; J Milhaud; B E Cohen; J Bolard
Journal: Antimicrob Agents Chemother Date: 1990-08 Impact factor: 5.191

4. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes.

Authors: H Rangel; F Dagger; A Hernandez; A Liendo; J A Urbina
Journal: Antimicrob Agents Chemother Date: 1996-12 Impact factor: 5.191

10. Immunogenicity and Efficacy of Live L. tarentolae Expressing KMP11-NTGP96-GFP Fusion as a Vaccine Candidate against Experimental Visceral Leishmaniasis Caused by L. infantum.

Authors: Vahid Nasiri; Abdolhossein Dalimi; Fatemeh Ghaffarifar; Azam Bolhassani
Journal: Iran J Parasitol Date: 2016 Apr-Jun Impact factor: 1.012

Recent developments in the chemotherapy of leishmaniasis.

1. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium.

2. UDP-Gal: N-acetylglucosamine beta 1-4 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis.

3. Enhanced action of amphotericin B on Leishmania mexicana resulting from heat transformation.

4. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes.

5. Suppression of Leishmania donovani by oral administration of a bis(benzyl)polyamine analog.

6. Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog.

7. Effect of ketoconazole on lethal action of amphotericin B on Leishmania mexicana promastigotes.

8. Trypanothione reductase: a viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design.

9. Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light.

10. Immunogenicity and Efficacy of Live L. tarentolae Expressing KMP11-NTGP96-GFP Fusion as a Vaccine Candidate against Experimental Visceral Leishmaniasis Caused by L. infantum.